Chemistry:Navafenterol
From HandWiki
Short description: Chemical compound
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C38H42N6O6S2 |
Molar mass | 742.91 g·mol−1 |
3D model (JSmol) | |
| |
|
Navafenterol is an investigational drug that had been evaluated for chronic obstructive pulmonary disease.[1] It is a Beta2 agonist and a muscarinic antagonist. Further development has been discontinued for strategic reasons.[2]
References
- ↑ "Navafenterol for chronic obstructive pulmonary disease therapy". Expert Opinion on Investigational Drugs 32 (4): 283–290. April 2023. doi:10.1080/13543784.2023.2199920. PMID 37017626.
- ↑ "Navafenterol - AstraZeneca". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800043459.
Original source: https://en.wikipedia.org/wiki/Navafenterol.
Read more |